Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul;50(7):3000605221110489.
doi: 10.1177/03000605221110489.

Autosomal dominant hypocalcemia with a novel CASR mutation: a case study and literature review

Yingying Wu  1   2 , Chao Zhang  1 , Xiaojun Huang  3 , Li Cao  2 , Shihua Liu  1 , Ping Zhong  1
Affiliations
Review

Autosomal dominant hypocalcemia with a novel CASR mutation: a case study and literature review

Yingying Wu et al. J Int Med Res. 2022 Jul.

Abstract

Autosomal dominant hypocalcemia type 1 (ADH1) is a rare inherited disorder characterized by hypocalcemia with low parathyroid hormone (PTH) levels and high urinary calcium. Its clinical presentation varies from mild asymptomatic to severe hypocalcemia. It is caused by gain-of-function mutations in the calcium-sensing receptor gene (CASR) which affect PTH secretion from the parathyroid gland and calcium resorption in the kidney. Here, we describe a case who presented with symptoms of recurrent seizure caused by hypocalcemia with a novel CASR variant. We comprehensively analyzed the phenotypic features of this presentation and reviewed the current literature to better understand clinical manifestations and the genetic spectrum.

Keywords: Autosomal dominant hypocalcemia type 1; CASR; calcification; hyperphospheremia; hypoparathyroidism; seizure.

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interest: The authors declare that there is no conflict of interest.

Figures

Figure 1.
Figure 1.
(a) Family pedigree. (b) Brain CT showing multiple calcifications in the bilateral frontal lobe, parietal lobe, temporal lobe, occipital lobe, basal ganglia, and cerebellum. (c) Sanger sequencing showing a CASR heterozygous mutation (c.416T > C) in the proband, and wild-type sequence in his parents and (d) Conservation of the 139th amino acid among different species.
See this image and copyright information in PMC

References

    1. Kwan B, Champion B, Boyages S, et al. A novel CASR mutation (p.Glu757Lys) causing autosomal dominant hypocalcaemia type 1. Endocrinol Diabetes Metab Case Rep 2018; 2018: 18–0107. - PMC - PubMed
    1. Pollak MR, Brown EM, Estep HL, et al. Autosomal dominant hypocalcaemia caused by a Ca(2 + )-sensing receptor gene mutation. Nat Genet 1994; 8: 303–307. - PubMed
    1. Papadopoulou A, Gole E, Melachroinou K, et al. Clinical characterization of a novel calcium sensing receptor genetic alteration in a Greek patient with autosomal dominant hypocalcemia type 1. Hormones (Athens, Greece) 2017; 16: 200–204. - PubMed
    1. Bastepe M. Gain-of-function CASR mutation causing hypocalcemia in a recessive manner. J Clin Endocrinol Metab 2018; 103: 3514–3515. - PMC - PubMed
    1. Choi KH, Shin CH, Yang SW, et al. Autosomal dominant hypocalcemia with Bartter syndrome due to a novel activating mutation of calcium sensing receptor, Y829C. Korean J Pediatr 2015; 58: 148–153. - PMC - PubMed

Supplementary concepts